Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years (Q36613420)
Jump to navigation
Jump to search
scientific article published on 3 February 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years |
scientific article published on 3 February 2012 |
Statements
Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years (English)
Christian Confavreux
David K Li
Mark S Freedman
Philippe Truffinet
Hadj Benzerdjeb
Dazhe Wang
Lucy E Reiman
Paul W O'Connor
Teriflunomide Multiple Sclerosis Trial Group
3 February 2012